| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 05/03/2001 | CA2388974A1 Medicament in order to induce tolerance |
| 05/03/2001 | CA2388965A1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1091775A1 Diphasic injection composition, in particular useful in reparative and plastic surgery |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/05/2001 | WO2001022989A2 Method to enhance healing of sternum after sternotomy |
| 04/05/2001 | WO2000072867A3 Substantially oil-free cyclosporin compositions |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | CA2385498A1 Method to enhance healing of sternum after sternotomy |
| 04/04/2001 | CN1063959C Composite sea-buckthorn oil capsule y |
| 04/03/2001 | US6211249 Polyester polyether block copolymers |
| 03/29/2001 | WO2001021789A1 Ribozymes used for restenosis prevention |
| 03/29/2001 | WO2001021628A1 A substantially cell membrane impermeable compound and use thereof |
| 03/29/2001 | WO2000054757A3 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 03/29/2001 | CA2385228A1 Ribozymes used for restenosis prevention |
| 03/28/2001 | EP1085920A1 Dextrin-containing composition for preventing surgical adhesions |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017531A1 Promotion of wound healing |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/08/2001 | WO2000054762A3 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 03/08/2001 | WO2000045804A3 Use of a polyanionic polysaccharide solution for the prevention of abscess formation |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/01/2001 | WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383559A1 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 02/22/2001 | WO2001012245A1 Joint lubricant |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2380927A1 Joint lubricant |
| 02/21/2001 | CN1284494A Bamboo parasitic fungus extract and its preparation and application |
| 02/21/2001 | CN1284356A Use of red sage in preventing post-operative adhesion of vertebral canal |
| 02/15/2001 | WO2001010323A1 Method of controlling body temperature while reducing shivering |
| 02/14/2001 | EP1075288A1 Compositions comprising hemostatic compounds and bioabsorbable polymers |
| 02/14/2001 | EP1075284A1 The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 02/08/2001 | WO2001009160A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2000067764A3 Improved method for treating mammals with modified mammalian blood |
| 02/08/2001 | CA2380545A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/07/2001 | EP1073413A1 Methods and compositions for stabilizing acetylcholine compositions |
| 02/06/2001 | US6183737 Bonding of cartilage pieces using isolated chondrocytes and a biological gel |
| 02/06/2001 | US6183593 Curable blend |
| 02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 01/25/2001 | WO2001005790A1 New compounds |
| 01/25/2001 | WO2001005443A1 Adhesive protein foam for surgical and/or therapeutic uses |
| 01/25/2001 | WO2000064930A3 Tribonectins |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1069902A1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/17/2001 | EP1068869A2 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 01/17/2001 | CN1279951A Use of ecdysterone in preparing medicine for angiocardiopathy |
| 01/16/2001 | US6174855 Pharmaceutical compositions comprising thrombin inhibitors and their use in the control of wound healing processes |
| 01/11/2001 | WO2000059515A3 Immunomodulating polymers |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/04/2001 | WO2001000246A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | CA2376714A1 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers |
| 12/28/2000 | WO2000078776A2 Thiophene a2a receptor agonists |
| 12/28/2000 | WO2000078259A1 Enhanced wound coverage to enhance wound healing |
| 12/28/2000 | CA2377371A1 Enhanced wound coverage to enhance wound healing |
| 12/26/2000 | CA2044878C Thermally reversible and irreversible gels |
| 12/21/2000 | WO2000076515A1 Il-8 receptor antagonists |
| 12/21/2000 | CA2377391A1 Il-8 receptor antagonists |
| 12/20/2000 | EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/20/2000 | CN1059597C Nerve injury recovery preparation |
| 12/14/2000 | WO2000075107A2 Bradykinin receptor antagonists |
| 12/14/2000 | WO2000074682A1 Thrombin inhibitors |
| 12/14/2000 | CA2374654A1 Thrombin inhibitors |
| 12/13/2000 | CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency |
| 12/07/2000 | WO2000072867A2 Substantially oil-free cyclosporin compositions |
| 12/07/2000 | CA2371247A1 Substantially oil-free cyclosporin compositions |
| 12/06/2000 | EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| 12/05/2000 | US6156800 Drugs for cardiovascular disorders and hypotensive agents |
| 12/05/2000 | US6156734 Cardiovascular disorders |
| 11/22/2000 | EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate |
| 11/16/2000 | WO2000067791A1 Ccr4 antagonists in sepsis |
| 11/16/2000 | WO2000067764A2 Improved method for treating mammals with modified mammalian blood |
| 11/16/2000 | WO2000067734A2 Use of phthalazine derivatives |